New study aims to catch pancreatic cancer early in genetically At-Risk patients
NCT ID NCT02478892
First seen Feb 05, 2026 · Last updated May 10, 2026 · Updated 11 times
Summary
This study looks at whether regular screening with endoscopic ultrasound or MRI can find early signs of pancreatic cancer in people who have a high inherited risk due to BRCA1/2, ATM, or PALB2 gene mutations. About 200 adults with these mutations will be monitored over time. The goal is to learn how often pre-cancerous or early cancerous lesions occur in this group and whether screening is a practical way to catch the disease sooner.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Abramson Cancer Center of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19004, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.